Insulet (PODD) Non-Current Deferred Tax Liability (2011 - 2012)

Insulet (PODD) reported Non-Current Deferred Tax Liability of $700000.0 for Q4 2012, down 22.22% on a YoY basis from $900000.0 in Q1 2012, and down 30.0% quarter-over-quarter from $1.0 million in Q3 2012.

Insulet (PODD) Non-Current Deferred Tax Liability (2011 - 2012) Analysis & Trends

Insulet has reported Non-Current Deferred Tax Liability for 2 years, with the latest figure at $700000.0 in Q4 2012.

  • For the quarter ending Q4 2012, Non-Current Deferred Tax Liability fell 22.22% year-over-year to $700000.0; the trailing twelve-month figure through Dec 2012 stood at $700000.0 (down 22.22% YoY), and the FY2012 full-year result was $700000.0, down 22.22% from the prior year.
  • Non-Current Deferred Tax Liability for Q4 2012 stood at $700000.0, down from $1.0 million in the prior quarter.
  • The five-year high for Non-Current Deferred Tax Liability was $5.5 million in Q2 2011, with the low at $700000.0 in Q4 2012.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Insulet 10.20 Bn 9.72 Bn 529.10 Mn

Historic Data

Download Data
DateValue
Dec 31, 2012 700,000.00
Dec 31, 2012 700,000.00
Sep 30, 2012 1.00 Mn
Sep 30, 2012 1.00 Mn
Jun 30, 2012 1.00 Mn
Jun 30, 2012 1.00 Mn
Mar 31, 2012 900,000.00
Mar 31, 2012 900,000.00
Dec 31, 2011 900,000.00
Dec 31, 2011 900,000.00
Jun 30, 2011 5.50 Mn
Jun 30, 2011 5.50 Mn